“Salvage chemotherapy” of malignant disease: importance of precisely defining the goals of treatment Maurie Markman Editorial Pages: 467 - 468
Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment K. JunkerM. ThomasK. -M. Müller Original Paper Pages: 469 - 477
Augmented human-tumor-cytolytic activity of peripheral blood lymphocytes and cells from a mixed lymphocyte/tumor culture activated by interleukin-12 plus interleukin-2, and the phenotypic characterization of the cells in patients with advanced carcinoma Shohei Koyama Original Paper Pages: 478 - 484
Loss of heterozygosity of thenm23-H1 gene in human renal cell carcinomas Maja Herak BosnarKrešimir PavelićJasminka Pavelić Original Paper Pages: 485 - 488
Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma Kumiyo AshidaYosuke KishimotoHironaka Kawasaki Original Paper Pages: 489 - 495
p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity Peter RöhlkeKarin Milde-LangoschThomas Löning Original Paper Pages: 496 - 501
Prognostic value of immunohistochemistry for p53 in primary soft-tissue sarcomas: a multivariate analysis of five antibodies Peter WürlHelge TaubertHenning Dralle Original Paper Pages: 502 - 508
Epstein-Barr virus in malignancies in renal transplant recipients in Japan Yoshihiko HoshidaYasuhiko TomitaKatsuyuki Aozasa Original Paper Pages: 509 - 513
Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer Gerald G. WulfBritta JürgensBernhard Wörmann Original Paper Pages: 514 - 521
Isozymes of nuclear protein tyrosine kinase during chemical induced hepatocarcinogenesis in rats H. ZhangY. HuangH. -L. Chen Rapid Communication Pages: 527 - 529
